Pill for breast cancer diagnosis may outperform mammograms
A research team is developing an oral infrared-lightactivated imaging agent that lights up breast tumors to better distinguish malignant from benign lesions, potentially reducing unnecessary procedures and improving detection. In mice, the dye attached to a repurposed drug travels through the body and makes tumors glow under infrared light, offering a safer alternative to mammograms by avoiding intravenous dyes.